PER3 rs10425708: Sleep Duration and Circadian Biology
rs10425708 is a common single nucleotide polymorphism located within the PER3 (period circadian regulator 3) gene on chromosome 1. Genome-wide association and candidate gene studies have linked this variant to individual differences in habitual sleep duration, sleep architecture, and sensitivity to acute sleep restriction. While it offers intriguing insights into circadian biology, its overall statistical effect on daily sleep patterns is modest.
What each genotype means
Typical sleep duration and resilience
You carry two copies of the C allele at rs10425708, which represents the most common genotype in most global populations. In sleep and circadian research, this baseline genotype is generally linked to average habitual sleep duration and typical tolerance to short-term sleep deprivation. However, evidence remains limited and modest in scale, meaning your overall sleep quality and fatigue levels are influenced far more by lifestyle, schedule consistency, and sleep hygiene than by this genetic variant alone.
Carried by approximately 40% to 50% of individuals of European ancestry and is the predominant genotype across East Asian and African ancestries.
Intermediate sleep architecture tendency
You carry one copy of the C allele and one copy of the G allele at rs10425708. Genome-wide association and circadian candidate studies suggest an intermediate profile, with modest associations with altered sleep timing, slow-wave sleep distribution, and vulnerability to sleep debt. Because findings across studies are mixed and statistical effect sizes are subtle, this genotype does not indicate a sleep disorder or guarantee noticeable shifts in your natural sleep patterns.
Carried by roughly 40% to 45% of individuals of European descent, but occurs at lower rates in East Asian and African populations.
Altered sleep duration tendency
You carry two copies of the G allele at rs10425708. In published sleep association studies, the minor G allele has been linked to subtle variations in habitual sleep duration, slow-wave sleep dynamics, and increased susceptibility to performance decrements following sleep loss. Current research evidence remains limited, and individual outcomes vary widely depending on personal sleep schedules, daytime light exposure, and broader environmental factors.
Carried by approximately 10% to 15% of people of European ancestry and is relatively uncommon in East Asian and African populations.
Genomic Context and Molecular Function
The single nucleotide variant rs10425708 resides on chromosome 1 within the PER3 gene, which encodes the period circadian regulator 3 protein. PER3 functions as a key component of the core circadian molecular feedback loop in humans. Within cells, PER proteins partner with cryptochrome (CRY) proteins to translocate into the nucleus and inhibit CLOCK-BMAL1 transcriptional complexes, establishing an endogenous roughly 24-hour cycle. In addition to regulating circadian timing across brain and peripheral tissues, PER3 is involved in the homeostatic regulation of sleep pressure, influencing how sleep need accumulates throughout wakefulness and dissipates during deep rest.
Research Associations and Evidence Strength
Research evaluated in sleep genome-wide association studies (GWAS) and candidate gene analyses has identified statistical associations between rs10425708 and traits such as habitual sleep duration, the distribution of slow-wave (deep) sleep, and waking neurobehavioral performance following sleep deprivation. However, current evidence is classified as limited. In large-scale population studies, common non-coding or synonymous single nucleotide polymorphisms in circadian clock genes typically exert subtle effect sizes. The variant often operates in linkage disequilibrium with other regional variations, such as the widely studied PER3 length polymorphism, meaning rs10425708 alone does not directly determine an individual's sleep phenotype.
Population Frequency and Ancestral Distribution
The rs10425708 variant is common across diverse human populations, although its exact allele distribution varies by ancestry. In individuals of European ancestry, the minor allele frequency is approximately 0.35, resulting in substantial numbers of heterozygous and minor homozygous carriers in public cohorts such as the UK Biobank and 1000 Genomes Project. Allele frequencies in East Asian, African, and South Asian populations demonstrate distinct baseline distributions in dbSNP and gnomAD. Because most sleep GWAS have historically focused on European cohorts, the phenotypic impact of rs10425708 in other ancestral groups remains an area of ongoing scientific investigation.
Interpreting Results and Practical Limitations
Knowing your rs10425708 genotype provides an educational glimpse into inherited circadian variability, but it is not a medical diagnosis and cannot predict clinical sleep disorders such as chronic insomnia or sleep apnea. Sleep architecture and circadian preferences are polygenic, shaped by thousands of variants alongside major environmental drivers. Light exposure, consistent sleep-wake timing, shift work, stress, and caffeine intake have a substantially larger impact on sleep quality and alertness than any single genetic variant. Individuals experiencing persistent sleep difficulties or daytime cognitive impairment should seek evaluation from a qualified sleep specialist or healthcare professional.
How common is this variant?
The minor allele frequency for rs10425708 is approximately 0.35 in European populations, making both heterozygous and homozygous genotypes common. Frequencies across other global ancestries vary in dbSNP and gnomAD datasets.
Frequently asked questions
Can rs10425708 determine if I am a morning lark or a night owl?
No, your rs10425708 genotype cannot definitively determine whether you are an early bird or a night owl. While PER3 variants are statistically linked to diurnal preferences, chronotype is a complex trait influenced by hundreds of genetic loci and everyday lifestyle habits.
Does having a specific rs10425708 genotype mean I need less sleep?
No, this genetic marker does not dictate that you can healthily survive on less sleep. Although researchers observe small statistical differences in habitual sleep length between genotypes, individual physiological sleep need is determined by complex biological systems and sleep debt.
Is rs10425708 associated with clinical sleep disorders?
Current scientific literature treats rs10425708 as a normal trait-associated polymorphism rather than a clinical mutation. It does not cause conditions such as obstructive sleep apnea, narcolepsy, or primary insomnia.
How can I support my circadian rhythm regardless of my genotype?
Maintaining a regular sleep-wake schedule, getting bright outdoor light exposure each morning, minimizing blue light at night, and avoiding late caffeine intake are proven strategies that support circadian health across all PER3 genotypes.
Sources & further reading
Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10425708?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PER3
This SNP is associated with chronotype scores in older adults, suggesting a role in circadian regulation.
This SNP is associated with average delta power during sleep, a marker of sleep intensity.
Missense variant P415A in PER3 associated with familial advanced sleep phase syndrome and circadian phase preference.
Common synonymous variant in PER3 tightly linked with circadian diurnal preference and morningness-eveningness tendencies.
Promoter/intronic variant of PER3 tagging circadian phase angle, diurnal preference, and homeostatic sleep pressure response to sleep loss.
Part of a well-characterized functional haplotype in PER3 influencing individual diurnal preference and susceptibility to delayed sleep phase syndrome.